Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment-Reference-Cited by-同舟云学术

Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment

Published:2011-01-12 Issue:1 Volume:17 Page:92-109
ISSN:1355-0284
Container-title:Journal of NeuroVirology
language:en
Short-container-title:J. Neurovirol.

Author:

Li Luna,Aiamkitsumrit Benjamas,Pirrone Vanessa,Nonnemacher Michael R.,Wojno Adam,Passic Shendra,Flaig Katherine,Kilareski Evelyn,Blakey Brandon,Ku Jade,Parikh Nirzari,Shah Rushabh,Martin-Garcia Julio,Moldover Brian,Servance Laila,Downie David,Lewis Sharon,Jacobson Jeffrey M.,Kolson Dennis,Wigdahl Brian

Publisher

Springer Science and Business Media LLC

Subject

Virology,Cellular and Molecular Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s13365-010-0014-1.pdf

Reference39 articles.

1. Boven LA, Noorbakhsh F, Bouma G, van der Zee R, Vargas DL, Pardo C, McArthur JC, Nottet HS, Power C (2007) Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13:173–184

2. Brockman W, Alvarez P, Young S, Garber M, Giannoukos G, Lee WL, Russ C, Lander ES, Nusbaum C, Jaffe DB (2008) Quality scores and SNP detection in sequencing-by-synthesis systems. Genome Res 18:763–770

3. Burdo TH, Gartner S, Mauger D, Wigdahl B (2004) Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 10(Suppl 1):7–14

4. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183–188

5. de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A (1992) Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757–765

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a latency model based on HIV-1 subtype C to study how long terminal repeat genetic variation impacts viral persistence and latency reversal;2024-08-02

2. Role of extracellular viral regulatory proteins in neuropathogenesis;HIV-Associated Neurocognitive Disorders;2024

3. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9;Frontiers in Genome Editing;2023-04-13

4. Trichoderma longibrachiatum T6: A nematocidal activity of endochitinase gene exploration and its function identification;International Journal of Biological Macromolecules;2022-12

5. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites;Molecular Therapy - Nucleic Acids;2020-09